Unmanipulated HaploidenticalReduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
2.
原著
Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
3.
原著
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
4.
原著
Update on granulocyte transfusions: accumulation of promising data, but still lack of decisive evidence. 2016/01
A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. 2018/04
7.
原著
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment. 2018/05
Aldehyde dehydrogenase activity in cryopreserved cord blood cells for quality assessment prior to transplantation. 2018/11
11.
原著
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
12.
研究報告
兵庫医科大学病院における細胞治療製剤(テムセルHS注®)の管理・運用体制の構築 2019/06
13.
原著
Early evaluation of tumor response to90 2019/07
14.
原著
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
15.
原著
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP. 2019/09
16.
研究報告
細胞治療製剤(テムセルHS注®)の生細胞率測定による品質評価 2020/01
17.
総説
顆粒球採取および顆粒球輸血療法の現状と課題 2020/01
18.
原著
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
19.
原著
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion 2020/06
20.
研究報告
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis 2021/04
Expression of activated integrin β7 in multiple myeloma patients 2021/07
23.
原著
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy 2021/09
24.
原著
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia 2021/10
25.
症例報告
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma 2021/12
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis 2022/01
28.
原著
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain 2022/02
29.
症例報告
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone 2022/02
30.
総説
当院におけるCAR-T療法導入を契機とした輸血・細胞治療向け品質管理体制の構築 2022/02
31.
原著
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy. 2022/07
Grade Of CRS Is Associated With Cardiac Dysfunction In The Acute Phase, But Do Not Predict The Prognosis Of Difuse Large B Cell Lymphoma Patients Who Underwent CAR-T Therapy. (ポスター掲示,一般) 2022/11/06